Robert S. Schwartz, Ph.D.

Schwartz Robert

Bob Schwartz is a patent litigator whose practice focuses on life sciences litigation, inter partes review (IPR), and post-grant review (PGR). The technology areas Bob has experience in include vaccines, fusion proteins, immunoglobulins, siRNA, DNA sequencing, and small-molecule pharmaceuticals. Prior to becoming an attorney, he was a professor at the Albert Einstein College of Medicine, where he was a principal investigator conducting grant-funded biomedical research. He also formerly served as a staff scientist at Children's Hospital Oakland Research Institute (CHORI). Bob leads Venable’s BiologicsHQ where he has published more than 100 articles and blog posts related to biologics and biosimilars.


Representative Matters

  • Represented Columbia University against Illumina in a patent litigation and IPRs related to DNA sequencing products
  • Represented Gilead against Teva in an abbreviated new drug application (ANDA) patent litigation related to Atripla® and Truvada® products
  • Represented GlaxoSmithKline against Teva in an ANDA patent litigation related to GlaxoSmithKline’s Avodart® product
  • Represented Bristol-Myers Squibb against Repligen and Zymogenetics in patent litigations related to Bristol-Myers Squibb’s Orencia® product
  • Represented GlaxoSmithKline against Dr. Reddy’s Laboratories, Cobalt Pharmaceuticals, and Spectrum Pharmaceuticals in ANDA patent litigations related to GlaxoSmithKline’s Imitrex® product
  • Represented G.D. Searle and Pharmacia against the University of Rochester in a patent litigation related to G.D. Searle and Pharmacia’s Celebrex® product, an NSAID small molecule drug
  • Represented Sanofi and Regeneron against Genentech in a patent litigation related to Eylea®. The matter involved fusion protein therapeutics and immunoglobulin-producing mice

Representative Clients

  • Advaxis
  • Alnylam
  • AstraZeneca
  • Bristol-Myers Squibb
  • Columbia University
  • GlaxoSmithKline
  • Regeneron
  • Sanofi




  • J.D. magna cum laude Pace University School of Law 2003
    • Editor, Pace Law Review
  • Ph.D. Biochemistry summa cum laude University of California at Berkeley
  • B.S. Biology magna cum laude State University of New York at Albany
  • B.A. Music State University of New York at Albany

Bar Admissions

  • New York

Court Admissions

  • U.S. Court of Appeals for the Federal Circuit
  • U.S. District Court for the Western District of New York
  • U.S. District Court for the Southern District of New York

Professional Memberships and Activities

  • Authored more than 40 scientific articles and book chapters published in peer-reviewed journals, and numerous articles related to patentability, biologics, and biosimilars
  • Frequent speaker at conferences on biologics and biosimilars


  • Legal 500, Patent Litigation – Full Coverage, 2007, 2014